Sodium-glucose cotransporter-2 inhibitor-induced euglycemic diabetic ketoacidosis: A case report

被引：0
|
作者：
Han, Jingjing [1 ]
Xie, Shuo [1 ]
Jiao, Hongmei [1 ]
机构：
[1] Peking Univ First Hosp, Dept Geriatr, Beijing 100034, Peoples R China
来源：
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 2022年 / 47卷 / 09期
关键词：
D O I：
10.1111/jcpt.13737
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1482 / 1485
页数：4
相关论文
共 50 条
  • [41] Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers
    Somagutta, Manoj R.
    Agadi, Kuchalambal
    Hange, Namrata
    Jain, Molly S.
    Batti, Erkan
    Emuze, Bernard O.
    Amos-Arowoshegbe, Elizabeth O.
    Popescu, Sorin
    Hanan, Saad
    Kumar, Varadha Retna
    Pormento, Kezia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [42] A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old
    Petersen, Cyrena
    Gyabaah, Frederick
    Sotelo, Jose
    Yohanna, Sandeesh
    Deoker, Abhizith
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [43] Sodium-Glucose Cotransporter 2 Inhibitor-induced Ketoacidosis and Non-Ketotic Acidosis
    Fahy, Yvonne
    Laffey, John G.
    McNicholas, Bairbre
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (06) : 911 - 916
  • [44] Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy
    Meyer, Emily J.
    Mignone, Edward
    Hade, Anthony
    Thiruvenkatarajan, Venkatesan
    Bryant, Robert V.
    Jesudason, David
    DIABETES CARE, 2020, 43 (11) : E181 - E184
  • [45] EUGLYCEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES MELLITUS ON SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS INDUCED BY COVID-19
    AlSaraj, Fuad
    Krishnareddy, Kalpana
    Capatos, Gerasmos
    Medhat, Paula
    MEDICINE, 2021, 100 (33)
  • [46] Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports
    Khedr, Anwar
    Hennawi, Hussam Al
    Khan, Muhammed Khuzzaim
    Eissa, Aalaa
    Mir, Mikael
    Rauf, Ibtisam
    Nitesh, Jain
    Surani, Salim
    Khan, Syed Anjum
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (24) : 5700 - 5709
  • [47] Sodium-glucose cotransporter 2 inhibitor-induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction
    Cavka, Luka
    Bencak Ferko, Urska
    Pitz, Natasa
    Trpkovski, Zoranco
    Lainscak, Mitja
    ESC HEART FAILURE, 2021, 8 (04): : 2631 - 2636
  • [48] Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report
    Lindsay, Patrick J.
    Gibson, Lauren E.
    Bittner, Edward A.
    Berg, Sheri
    Chang, Marvin G.
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2020, 77 : 463 - 466
  • [49] Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor (vol 62, pg722, 2016)
    Jazi, M.
    Porfiris, G.
    CANADIAN FAMILY PHYSICIAN, 2016, 62 (11) : 877 - 877
  • [50] SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report
    Wang, Katherine M.
    Isom, Robert T.
    KIDNEY MEDICINE, 2020, 2 (02) : 218 - 221
12345